I saw a seminar by the CSO of this company this morning - this is a very smartly designed adenoviral therapy for cancer - its very promising. They have modified the virus to more specifically target cancer cells over normal tissue, and they have made it a lytic virus instead of lysogenic, so the virus lyses the cell, thus avoiding the complication of where the virus will be integrated into the genome. Very exciting to see viral gene therapy progressing forward again!